Evidence map›Paper›PMID 29948106›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2018

The role of FDG PET/CT in therapy control of aortic graft infection.

Lars Husmann, Bruno Ledergerber, Alexia Anagnostopoulos, Paul Stolzmann, Bert-Ram Sah, Irene A Burger, Roxana Pop, Alberto Weber, Dieter Mayer, Zoran Rancic and 2 more

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01821664 (Vascular Graft Infections - Epidemiology, Best Treatment Options, Imaging Modalities and Impact of Negative Pressure Wound Therapy), which is not on this map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01821664 unknown statusnot on this map

Vascular Graft Infections - Epidemiology, Best Treatment Options, Imaging Modalities and Impact of Negative Pressure Wound Therapy

Typeobservational_patient_registrySponsorUniversity of ZurichRan2013 to 2023Enrolled1,800ConditionsProsthetic Vascular Graft InfectionArmsProsthetic vascular graft
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Article
  4. Article
  5. Outcomes of conservative treatment for thoracic vascular graft infections.European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2025
    Article
  6. Article
  7. Article
  8. Imaging Inflammation Past, Present, and Future: Focus on Cardioimmunology.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  9. Article
  10. Review
  11. Diagnostic performance of quantitative and qualitative parameters for the diagnosis of aortic graft infection using [Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  12. Current cardiology reports · 2021
    Review
  13. Article
  14. Detection of aortic prosthetic graft infection withJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  15. Article
  16. State of the art ofClinical and translational imaging · 2021
    Review
  17. Observational
  18. Assessing cardiovascular infection and inflammation with FDG-PET.American journal of nuclear medicine and molecular imaging · 2021
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Lars HusmannClinic for Nuclear Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. lars.husmann@usz.ch.ORCID 0000-0002-5878-0818
Bruno LedergerberDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Alexia AnagnostopoulosDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Paul StolzmannClinic for Nuclear Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
Bert-Ram SahClinic for Nuclear Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
Irene A BurgerClinic for Nuclear Medicine, University Hospital Zurich, University of Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland.
Roxana PopDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Alberto WeberClinic for Cardiovascular Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Dieter MayerClinic for Cardiovascular Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Zoran RancicClinic for Cardiovascular Surgery, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Barbara HasseDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
VASGRA Cohort Study
University of Zurich · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung #32473B_163132/1
6 · The paper itself

Abstract

purpose

methodsParticipants of the prospective Vascular Graft Infection Cohort Study (VASGRA) were included if they had microbiologically proven AGI. We quantified the metabolic activity in PET/CT by using maximum standardized uptake value (SUV

resultsSixty-eight participants with AGI contributed to 266 PET/CTs including 36 examinations performed after stop of antimicrobial therapy. Higher C-reactive protein (CRP) (adjusted coefficient per log

conclusionsConsecutive PET/CTs could influence the clinical decision-making in patients with AGI in the near future. More studies on the use of PET/CT in case of aortic graft infection may offer the potential for individualized treatment approaches. CLINICALTRIALS. GOV IDENTIFIER: NCT01821664.

Indexed as

Fluorodeoxyglucose F18Positron Emission Tomography Computed TomographyAgedAortaFemaleHumansIncidental FindingsMaleMiddle AgedProsthesis-Related InfectionsVascular GraftingFluorodeoxyglucose F18Aortic vascular graft infectionPET/CTSUVmax, monitoringTreatment response

Identifiers

PMID29948106
OpenAlexW2808214631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.